Sugi Predict

Sugi Predict / Compounds / SCHEMBL6732665

SCHEMBL6732665

SCHEMBL6732665

Cc1ccc(-c2[nH]c(C(F)(F)F)nc2-c2cc(F)c(S(C)(=O)=O)cc2F)cc1C#N

nearest known ligand 0.34

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ FASN P49327 6/20 0.34
▸ NR1H2 P55055 4/20 0.34
▸ NR1H3 Q13133 3/20 0.34
▸ ALOX5AP P20292 2/20 0.33
▸ FEN1 P39748 2/20 0.33
▸ ESR1 P03372 1/20 0.32
▸ ESR2 Q92731 1/20 0.32
▸ PIK3CD O00329 1/20 0.32
▸ PIK3CA P42336 1/20 0.32
▸ PIK3CB P42338 1/20 0.32
▸ PIK3CG P48736 1/20 0.32
▸ PTGS2 P35354 3/20 0.32
▸ MAPK14 Q16539 1/20 0.31
▸ ALOX5 P09917 1/20 0.31
▸ TBK1 Q9UHD2 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6732561 0.93 NR1H2 (0.34) FASNNR1H2NR1H3ALOX5APFEN1
SCHEMBL6721387 0.89 ESR1 (0.35) FASNESR1ESR2PIK3CDPIK3CA
SCHEMBL6737168 0.88 PTGS2 (0.42) NR1H2NR1H3ALOX5APFEN1ESR1
SCHEMBL6733215 0.86 FASN (0.38) FASNNR1H2NR1H3ESR1ESR2
SCHEMBL6736737 0.86 NR1H2 (0.39) NR1H2NR1H3ALOX5APFEN1ESR1
SCHEMBL6733585 0.86 PTGS2 (0.42) NR1H2NR1H3ALOX5APFEN1ESR1
SCHEMBL6737092 0.85 NR1H2 (0.35) NR1H2NR1H3ALOX5APFEN1ESR1
SCHEMBL6728472 0.85 PTGS2 (0.45) NR1H2NR1H3ALOX5APFEN1ESR1
SCHEMBL6736089 0.85 TYK2 (0.35) ALOX5APFEN1PIK3CDPIK3CAPIK3CB
SCHEMBL6736484 0.84 NR1H2 (0.39) NR1H2NR1H3ALOX5APFEN1ESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040138261-A1 Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation PHARMACIA CORPORATION 2004-07-15 — — US disclosed
US-6699884-B2 ANTIINFLAMMATORY CYCLOOXYGENASE INHIBITORS. PHARMACIA CORPORATION 2004-03-02 — — US disclosed
US-6673818-B2 TREATING CYCLOOXYGENASE-2 MEDIATED DISORDERS, SUCH AS ARTHRITIS, PAIN, FEVER AND CANCER PHARMACIA CORPORATION 2004-01-06 — — US disclosed
US-20030149078-A1 Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation PHARMACIA CORPORATION 2003-08-07 — — US disclosed
US-20030032657-A1 Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation PHARMACIA CORPORATION 2003-02-13 — — US disclosed
EP-1251126-A2 Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation Pharmacia Corporation (US) 2002-10-23 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040138261-A1 Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation FPR1, FPR2, FPR3 FASN 134/4885NR1H2 173/4885NR1H3 299/4885
US-20030149078-A1 Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation FPR1, FPR2, FPR3 FASN 134/4885NR1H2 173/4885NR1H3 299/4885
US-20030032657-A1 Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation FPR1, FPR2, FPR3 FASN 134/4885NR1H2 173/4885NR1H3 299/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.